A case of sudden-onset hearing Loss in a patient treated with peginterferon α-2b and ribavirin for chronic hepatitis C
Korean J Hepatol. 2009;15(3):370-374. Published online 2009 Sep 30 DOI: https://doi.org/10.3350/kjhep.2009.15.3.370
Citations to this article as recorded by 
A Narrative Review of Pharmacologic Treatments for COVID‐19: Safety Considerations and Ototoxicity
Christine Little, Maura K. Cosetti
The Laryngoscope.2021; 131(7): 1626. CrossRef
Cochlear Changes Caused by Peginterferon α-2b
Reham F. Zittoon, Yasser T. Madian, Diaa Eldeen M. Alhennawi, Hany S. Nadeem
Journal of Interferon & Cytokine Research.2018; 38(7): 311. CrossRef
Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy
Savita Jain, Vandana Midha, Ajit Sood
Indian Journal of Gastroenterology.2011; 30(5): 239. CrossRef